BCI
ROIV icon

Brinker Capital Investments’s Roivant Sciences ROIV Stock Holding History

Brinker Capital Investments’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$914K Buy
25,821
+15,245
+144% +$451K 0.01% 1204
2026
Q1 		$293K Buy
10,576
+175
+2% +$4.5K ﹤0.01% 1674
2025
Q4 		$226K Buy
10,401
+24
+0.2% +$474 ﹤0.01% 1958
2025
Q3 		$157K Sell
10,377
-46
-0.4% -$569 ﹤0.01% 1996
2025
Q2 		$117K Buy
+10,423
New +$113K ﹤0.01% 1936

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Brinker Capital Investments's ROIV Position: Q2 2026 in Review

Brinker Capital Investments increased its Roivant Sciences (ROIV) stake by 144% in Q2 2026, buying an estimated $451K and bringing the position to 25,821 shares worth $914K. The position accounts for 0.01% of the portfolio, ranked #1204.

Brinker Capital Investments first reported a position in ROIV in Q2 2025 and has held it in 5 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Brinker Capital Investments held 25,821 shares of Roivant Sciences worth $914K as of Q2 2026.
  • Brinker Capital Investments bought 15,245 Roivant Sciences shares in Q2 2026, an estimated $451K.
  • Roivant Sciences made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1204 holding.
  • Brinker Capital Investments first reported a position in Roivant Sciences in Q2 2025 and has held it in 5 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.